What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: BioChem
95%DGNews: Europe Recommends Approval Of Trizivir (Lamivudine, Abacavir Sulphate and Zidovudine) For HIV
94%DGNews: Zeffix Approved In Taiwan For Chronic Hepatitis B
93%DGNews: FDA Approves Pacis BCG For Treatment Of Bladder Cancer
93%DGNews: European Phase II/III Pivotal 3TC/AZT Data Published in Jama
92%DGNews: Cell-Culture Flu Vaccine Safely Boosts Immunity
92%DGNews: Encouraging Open-Label Phase II Lamivudine Data
91%DGNews: DRUG RESISTANCE MEETING: Epivir Remains Active Against HIV With Common Resistance Mutation
90%DGNews: Extract of Patient's Own Colonic Mucosal Proteins Effective in Crohn's Disease, Study Finds
90%DGNews: Zefix Tablets 100 (Lamivudine) Launched In Japan For Hepatitis B
90%DGNews: Viral suppression in hepatitis B continues after termination of Zeffix (lamivudine) therapy
90%DGNews: Researchers Using Gene Therapy To Protect Human Cells From HIV
90%DGNews: Heptovir Approved In Canada For Chronic Hepatitis B
89%DGNews: Liver Damage Improved With Zeffix (Lamivudine) Treatment In Hepatitis B Patients
89%DGNews: Zeffix Improves Liver Disease, Suppresses Virus in Hepatitis B Patients
88%DGNews: European Union Approves Trizivir Triple Combination Tablet For HIV Treatment
88%DGNews: Up To 65 percent Of Patients With Chronic Hepatitis B Seroconvert With Zeffix
88%DGNews: BioChem, Biovector to develop novel nasally delivered vaccines
87%DGNews: Lamivudine Reduces Liver Damage Due to Chronic Hepatitis B -- Study
87%DGNews: Epivir-HBV (Lamivudine) Shows Promise in Hepatitis B Patients
87%DGNews: Japan Approves Antiviral Zevix (Lamivudine) For Hepatitis B
87%DGNews: New Guidelines Endorse Zeffix (Lamivudine) As Key Treatment Option For Hepatitis B
87%DGNews: Zeffix Approved For Chronic Hepatitis B Treatment In The E.U.
87%DGNews: Expanded Orphan Drug Designation for NTZ
87%DGNews: NTZ Granted Expanded Access for AIDS Patients with Cryptosporidiosis
86%DGNews: Kivexa, One Tablet Once a Day Simplifies Treatment for HIV Patients
86%DGNews: Combivir Approved In Canada For HIV Treatment
86%DGNews: NTZ Phase II/III Trial With AIDS Clinical Trials Group
86%DGNews: EASL: Lamivudine Effective For Most Hepatitis B Patients
86%DGNews: EASL MEETING: Zeffix May Offer Long-Term Benefits For Chronic Hepatitis B Patients
86%DGNews: Positive Results With NTZ for Cryptosporidial Diarrhea in AIDS Patients
85%DGNews: Heptodin Launched In China For Hepatitis B
85%DGNews: Zeffix May Reduce Incidence Of Post-Liver Transplant Hepatitis B Re-infection
85%DGNews: Epivir Delays HIV Disease Progression or Death
85%DGNews: EU Committee Backs Zeffix For Chronic Hepatitis B
83%DGNews: Canada Approves Trizivir (Lamivudine/Zidovudine/AZT/Abacavir) For Human Immunodeficiency Virus
81%DGNews: Study Shows Efficacy Of Oral Epivir-HBV In Hepatitis B
81%DGNews: Incel May Reduce Disease Progression In Ovarian Cancer Patients
80%DGNews: Epivir Study Shows Reduction in HIV Disease Progression or Death
79%DGNews: FDA Approves Anti-HIV Drug, Trizivir (Lamivudine, Zidovudine And Abacavir)
78%DGNews: EASL: Zeffix (Lamivudine) Induces Virologic Response In Children With Hepatitis B
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.